CA2106868A1 - Compounds for use in the treatment of cancer - Google Patents
Compounds for use in the treatment of cancerInfo
- Publication number
- CA2106868A1 CA2106868A1 CA002106868A CA2106868A CA2106868A1 CA 2106868 A1 CA2106868 A1 CA 2106868A1 CA 002106868 A CA002106868 A CA 002106868A CA 2106868 A CA2106868 A CA 2106868A CA 2106868 A1 CA2106868 A1 CA 2106868A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- formula
- electron
- hydroxymethyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919106170A GB9106170D0 (en) | 1991-03-22 | 1991-03-22 | New compounds for use in the treatment of cancer |
| GB9106170.5 | 1991-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2106868A1 true CA2106868A1 (en) | 1992-09-23 |
Family
ID=10692068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002106868A Abandoned CA2106868A1 (en) | 1991-03-22 | 1992-03-23 | Compounds for use in the treatment of cancer |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0505220A1 (enExample) |
| JP (1) | JPH06511229A (enExample) |
| AU (1) | AU1566792A (enExample) |
| CA (1) | CA2106868A1 (enExample) |
| GB (1) | GB9106170D0 (enExample) |
| IE (1) | IE920889A1 (enExample) |
| IL (1) | IL101317A0 (enExample) |
| MX (1) | MX9201258A (enExample) |
| TW (1) | TW202437B (enExample) |
| WO (1) | WO1992016513A1 (enExample) |
| ZA (1) | ZA922073B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9206768D0 (en) * | 1992-03-27 | 1992-05-13 | Jarman Michael | New compounds for use in the treatment of cancer |
| GB9219776D0 (en) * | 1992-09-18 | 1992-10-28 | Inst Of Cancer The Research | New compounds for use in the treatment of cancer |
| JP2002509140A (ja) * | 1998-01-13 | 2002-03-26 | アナディーズ・ファーマスーティカルズ，インコーポレイテッド | トリアジン抗ウイルス化合物 |
| US6335339B1 (en) | 1998-01-13 | 2002-01-01 | Scriptgen Pharmaceuticals, Inc. | Triazine antiviral compounds |
| WO2009157628A1 (en) * | 2008-06-23 | 2009-12-30 | Industry-Academic Cooperation Foundation, Yonsei University | Pharmaceutical composition for treating or preventing cancer comprising triazine compound as an active ingredient |
| CN101684115B (zh) * | 2008-09-26 | 2011-12-21 | 上海医药工业研究院 | 4-(5-((2-(4-吗啉基-6-苯氨基-1,3,5-三嗪-2-基)亚肼基)甲基)呋喃-2-基)苯甲酸、其制备方法及用途 |
| BR112015011213A2 (pt) * | 2012-11-15 | 2017-08-29 | Galleon Pharmaceuticals Inc | Composto, composição farmacêutica, método de prevenção ou tratamento de um distúrbio ou doença de controle respiratório em um indivíduo, método de prevenção de desestabilização ou de estabilização do ritmo respiratório em um indivíduo, método de preparação de o,n-dimetil-n-[4-(n-propilamina)-6-(prop-2-inilamina)-[1,3,5]triazin-2-il]-hidroxilamina, e composição. |
-
1991
- 1991-03-22 GB GB919106170A patent/GB9106170D0/en active Pending
-
1992
- 1992-03-20 ZA ZA922073A patent/ZA922073B/xx unknown
- 1992-03-20 IE IE088992A patent/IE920889A1/en unknown
- 1992-03-20 MX MX9201258A patent/MX9201258A/es unknown
- 1992-03-20 IL IL101317A patent/IL101317A0/xx unknown
- 1992-03-21 TW TW081102138A patent/TW202437B/zh active
- 1992-03-23 CA CA002106868A patent/CA2106868A1/en not_active Abandoned
- 1992-03-23 WO PCT/GB1992/000525 patent/WO1992016513A1/en not_active Ceased
- 1992-03-23 JP JP4506407A patent/JPH06511229A/ja active Pending
- 1992-03-23 EP EP92302491A patent/EP0505220A1/en not_active Ceased
- 1992-03-23 AU AU15667/92A patent/AU1566792A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IE920889A1 (en) | 1992-09-23 |
| GB9106170D0 (en) | 1991-05-08 |
| TW202437B (enExample) | 1993-03-21 |
| ZA922073B (en) | 1992-11-25 |
| EP0505220A1 (en) | 1992-09-23 |
| MX9201258A (es) | 1992-10-01 |
| JPH06511229A (ja) | 1994-12-15 |
| IL101317A0 (en) | 1992-11-15 |
| WO1992016513A1 (en) | 1992-10-01 |
| AU1566792A (en) | 1992-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0711760B1 (en) | Method of alkylating triazine derivative | |
| EP0894087B1 (en) | Method for obtaining pure enantiomers of a pyridazinone derivative | |
| CN101759601B (zh) | 利用过渡金属配合物制备手性α-非天然氨基酸的方法 | |
| EP0422566B1 (en) | A process for the preparation of 3-(L-pyroglutamyl)-L-thiazolidine-4-carboxylic acid derivatives | |
| EP0505220A1 (en) | New compounds for use in the treatment of cancer | |
| EP0882720B1 (en) | Methods for modifying 1,3,5-triazine derivatives | |
| JPS60233102A (ja) | キトサン誘導体の製造方法 | |
| JPS5824569A (ja) | イミダゾ−ル誘導体の精製方法 | |
| CA2319219A1 (en) | Method for modifying melamine derivatives | |
| Bader | s-Triazines. IV. 1a Synthesis of Trisubstituted s-Triazines by Reaction of Acylimidates with Amidines | |
| Controulis et al. | Alkoxy-s-triazines | |
| EP2502625A1 (en) | Process for the preparation of crystalline levofolinic acid | |
| SK283188B6 (sk) | Spôsob prípravy kryštalickej formy 3/2 hydrátu 7-[(7-(S)- amino-5-azaspiro[2.4]-heptan-5-yl]-8-chlór-6-flór-1-[(1R,2S)-2- flórcyklopropyl]-4-oxo-1,4-dihydrochinolín-3-karboxylovej kyseliny | |
| EP0404197A3 (en) | Arylalkylamine derivatives | |
| CA1253499A (en) | Arphemenine-related compounds and uses thereof | |
| ZA200101587B (en) | Process for the production of N-protected azetidine-2-carboxylic acids (AzeOHs). | |
| KR850001699B1 (ko) | 아릴치환된 아미디노 우레아 유도체의 제조방법 | |
| Shealy et al. | Synthesis of 5‐(3, 3‐Disubstituted‐1‐triazenyl) imidazole‐4‐carbonitriles | |
| JP2006083155A (ja) | テアニンの製造方法 | |
| JPH0586791B2 (enExample) | ||
| JPH0827128A (ja) | トリアジン誘導体のアルキル化方法 | |
| Furin et al. | Guanidine in the synthesis of perfluoroalkylpyrimidines and perfluoroalkyl-s-triazines | |
| HU204032B (en) | New process for produicng substituted anilines | |
| Chakrabarti et al. | s-triazines—VII: Synthesis of dihalogeno-heteroaryl-s-triazines. Reaction of 2, 4, 6-trichloro-s-triazine with N-heteroaromatic rings | |
| Harris | V.—The optically active neo methylhydrindamines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 19960924 |